William M. Moore - Concepedia

Author

William M. Moore

Also Known As

Moore, William, Moore, William M., W M Moore, W M O Moore, W Moore, W. M. MOORE, W. M. Moore, W. M. O. MOORE, W. M. O. Moore, W. MOORE

163

Publications

5.9K

Citations

H-Index

169

Concepts

All Affiliations

Monsanto (United States)University of Manchester Pfizer (United States)University of Alabama at Birmingham Lexington Medical Center

About

William M. Moore is an author at Monsanto (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	59	4K
2	Natural Sciences	15	16	1.4K
3	Health Sciences	4	4	189
4	Engineering	2	2	64
5	Education	1	1	81

William M. Moore

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine Thomas P. Misko, William M. Moore, Thomas P. Kasten, European Journal of Pharmacology Selective InhibitionMolecular PharmacologyBiochemistryReactive Nitrogen SpecieMedicine	1993	724
L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase William M. Moore, R. Keith Webber, Gina Jerome, Journal of Medicinal Chemistry	1994	459
Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase Jane R. Connor, Pamela T. Manning, Steven L. Settle, European Journal of Pharmacology InflammationRheumatologySelective InhibitionRheumatoid DisorderAnti-inflammatory	1995	301
Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation Ronald G. Tilton, Katherine Chang, Khalid S. Hasan, Diabetes	1993	288
Head Circumference Reference Data: Birth to 18 Years Alex F. Roche, Debabrata Mukherjee, Shumei Guo, PEDIATRICS Gross AnatomyPopulation ChildrenBody SizeReference DataChild Health	1987	236
A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics Trevor T. Hansel, Sergei A. Kharitonov, Louise Donnelly, The FASEB Journal AsthmaInflammatory Lung DiseaseLung InflammationNitric OxideImmunology	2003	207
Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Ellen G. McMahon, Maria A. Palomo, William M. Moore, Proceedings of the National Academy of Sciences InflammationMolecular PharmacologyAngiogenesisPorcine Big Endothelin-1-Big Endothelin-1	1991	165
Results of the ANCHOR prospective, multicenter registry of EndoAnchors for type Ia endoleaks and endograft migration in patients with challenging anatomy William D. Jordan, David Varnagy, William M. Moore, Journal of Vascular Surgery Multicenter RegistryTransplantation SurgeryEndograft MigrationType Ia EndoleaksMedicine	2014	137
The Influence of Severity of Spinal Cord Ischemia in the Etiology of Delayed-onset Paraplegia William M. Moore, Larry H. Hollier Annals of Surgery	1991	127
Characterization of human uroguanylin: a member of the guanylin peptide family Toshihiro Kita, Christine E. Smith, Kam F. Fok, American Journal of Physiology-Renal Physiology Molecular PharmacologyProtein SecretionCgmp LevelsBiochemistryHuman Uroguanylin	1994	122

Page 1